Cyble’s 2026 healthcare threat report flags a sharp rise in Asia-focused ransomware, with hospitals, elderly care, and diagnostic systems increasingly in cybercriminal crosshairs
The new capital is expected to fund the company through 2029
The trial also demonstrated significant improvements across multiple secondary endpoints
As part of the deal, Red Nucleus also gains indirect ownership of the company’s Indian arm
Samsung Biologics will continue supplying products previously manufactured at the site to GSK
The study met its primary endpoint, showing a statistically significant and clinically meaningful improvement in progression-free survival
The JADE trial enrolled 164 U.S. patients who initially received three monthly doses of OLN324 or faricimab, followed by 12 weeks off treatment with retreatment allowed only if disease recurred
Hands-on clinical workshop in Bengaluru brings together neurologists, ENT specialists and physicians
Developed for today’s fast-paced, visually demanding lifestyles, the lenses are built on ZEISS NeurOptix technology
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
